Review of the literature regarding hearing loss in patients with head and neck cancer treated with chemoradiation.
Studies in the literature are reviewed that pertain to hearing loss sustained in head and neck cancer patients receiving cisplatin-based chemoradiation. Personal observations noted while treating these patients are also detailed.
PubMed was searched for pertinent articles regarding hearing loss in head and neck cancer patients receiving cisplatin chemotherapy and/or radiation.
Studies on the incidence and severity of hearing loss in head and neck cancer patients are limited, but those studies suggest that the risk of hearing loss is greater with higher-dose regimens.
Brandi Page, M.D.
Assistant Professor of Radiation Oncology and Molecular Radiation Sciences
Nicole Schmitt, M.D.
Assistant Professor of Otolaryngology - Head and Neck Surgery